Trends in the Use of Antibiotics for Open Forearm Fractures in Pediatric Patients From 2015 to 2023

Luke Sang1,2, Divij Sharma1, Michaela Booker1

  • 1Department of Orthopaedic Surgery, University of California San Francisco, San Francisco, CA, USA.

Insights

Antibiotic use for pediatric open fractures shows improved adherence for less severe types, but variability persists for severe fractures. Further studies are needed to standardize treatment protocols for type IIIA-C pediatric open fractures.

Area of Science:

  • Pediatric Orthopedics
  • Infectious Disease Management
  • Pharmacology

Background:

  • Antibiotic prophylaxis is crucial for pediatric open fractures to prevent infection.
  • Current guidelines recommend specific antibiotic regimens based on fracture severity.
  • Practices may vary, necessitating an assessment of current antibiotic use trends.

Purpose of the Study:

  • To evaluate contemporary antibiotic prescribing patterns for pediatric open fractures.
  • To identify trends in antibiotic selection across different fracture severities (Gustilo-Anderson classification).
  • To assess adherence to established standards of care in antibiotic prophylaxis.

Main Methods:

  • Retrospective review of the Pediatric Health Information System database (October 2015 - December 2023).
  • Inclusion of patients aged 18 years or younger with open forearm fractures.
  • Analysis of antibiotic data using Fisher's exact, Chi-squared, and Mann-Kendall tests.

Main Results:

  • A total of 1,224 pediatric patients were analyzed.
  • Cephalosporins, primarily cefazolin, were used in 95.7% of cases.
  • Type I/II fractures predominantly received single cefazolin (93.4%), while type IIIA-C fractures more often received multiple cephalosporins (11.8%) or additional antibiotics (8.8%).
  • A significant increase in cephalosporin use and single antibiotic therapy was observed for type I/II fractures between 2015-2023 (P < .05).

Conclusions:

  • Adherence to antibiotic standards of care has improved for pediatric type I/II open fractures.
  • Variability in antibiotic selection for type IIIA-C pediatric open fractures persists, indicating a need for further standardization.
  • Additional research is recommended to establish optimal antibiotic protocols for severe pediatric open fractures.
Abstract

Related Concept Videos

Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...